These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17434253)

  • 21. Lymphovascular invasion as an independent predictor of recurrence and survival in node-negative bladder cancer remains to be proven.
    Reuter VE
    J Clin Oncol; 2005 Sep; 23(27):6450-1. PubMed ID: 16129842
    [No Abstract]   [Full Text] [Related]  

  • 22. Optimal timing of radical cystectomy for patients with T1 bladder cancer.
    Bochner BH
    Urol Oncol; 2009; 27(3):329-31. PubMed ID: 19414124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Witjes JA
    Eur Urol; 2009 Apr; 55(4):919. PubMed ID: 18722044
    [No Abstract]   [Full Text] [Related]  

  • 24. Editorial comment on: Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Herr HW
    Eur Urol; 2009 Apr; 55(4):920-1. PubMed ID: 18722043
    [No Abstract]   [Full Text] [Related]  

  • 25. [Why and how to modify standard cystectomy].
    Gotsadze DT; Chakvetadze VT; Danelia EV
    Urologiia; 2008; (2):22-6. PubMed ID: 18572764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The adverse consequences of delaying radical cystectomy.
    Chang SS
    Nat Clin Pract Urol; 2006 Jun; 3(6):300-1. PubMed ID: 16763637
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of laparoscopic and open radical cystoprostatectomy for localized bladder cancer with 3-year oncological followup: a single surgeon experience.
    Hemal AK; Kolla SB
    J Urol; 2007 Dec; 178(6):2340-3. PubMed ID: 17936813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
    Bastian PJ; Hutterer GC; Shariat SF; Rogers CG; Palapattu GS; Lotan Y; Vazina A; Amiel GE; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP; Karakiewicz PI;
    BJU Int; 2008 Feb; 101(4):450-4. PubMed ID: 17850359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
    Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
    J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upper urinary tract recurrence following radical cystectomy for bladder cancer.
    Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M
    Int J Urol; 2007 Jun; 14(6):496-9. PubMed ID: 17593092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion.
    Lee CT; Dunn RL; Ingold C; Montie JE; Wood DP
    Urology; 2007 Jun; 69(6):1068-72. PubMed ID: 17572188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus.
    Maffezzini M; Campodonico F; Canepa G; Gerbi G; Parodi D
    Surg Oncol; 2008 Jul; 17(1):41-8. PubMed ID: 17962014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
    Isbarn H; Karakiewicz PI; Shariat SF; Capitanio U; Palapattu GS; Sagalowsky AI; Lotan Y; Schoenberg MP; Amiel GE; Lerner SP; Sonpavde G
    J Urol; 2009 Aug; 182(2):459-65; discussion 465. PubMed ID: 19524971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Dhar NB; Jones JS; Reuther AM; Dreicer R; Campbell SC; Sanii K; Klein EA
    BJU Int; 2008 Apr; 101(8):969-72. PubMed ID: 18005201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome.
    Ayres BE; Gillatt D; McPhail S; Cottrell A; McGrath J; Cottier B; Verne J; Persad RA;
    BJU Int; 2008 Sep; 102(8):1045. PubMed ID: 18840144
    [No Abstract]   [Full Text] [Related]  

  • 38. Alternatives to cystectomy in muscle-invasive bladder cancer.
    Goel S
    J Clin Oncol; 2003 Aug; 21(15):3003; author reply 3003-4. PubMed ID: 12885826
    [No Abstract]   [Full Text] [Related]  

  • 39. The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer.
    Ide H; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    Jpn J Clin Oncol; 2008 May; 38(5):360-4. PubMed ID: 18490370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.